Serum CEACAM1 Elevation Correlates with Melanoma Progression and Failure to Respond to Adoptive Cell Transfer Immunotherapy

Table 1

The correlations between sCEACAM1, LDH, and days in melanoma patients.

	LDH versus sCEACAM1	LDH versus days	sCEACAM1 versus days
Correlation coefficient	0.764	0.19	0.202
Significance (2-tailed)	0	0.354	0.323

Spearman nonparametric correlation was used to assess the relationships between the changes of sCEACAM1 and LDH following treatment and between the differences in time intervals of testing points between patients and each of the markers.